Form 8-K - Current report:
SEC Accession No. 0001193125-25-070926
Filing Date
2025-04-02
Accepted
2025-04-02 08:15:20
Documents
15
Period of Report
2025-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d923788d8k.htm   iXBRL 8-K 47745
2 EX-2.1 d923788dex21.htm EX-2.1 601360
3 EX-99.1 d923788dex991.htm EX-99.1 8167
  Complete submission text file 0001193125-25-070926.txt   937246

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA allk-20250401.xsd EX-101.SCH 2850
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE allk-20250401_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allk-20250401_pre.xml EX-101.PRE 11261
17 EXTRACTED XBRL INSTANCE DOCUMENT d923788d8k_htm.xml XML 3623
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 25802263
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)